{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T05:13:22Z","timestamp":1675833202595},"reference-count":0,"publisher":"Medical Journals Sweden AB","content-domain":{"domain":["www.medicaljournals.se"],"crossmark-restriction":false},"short-container-title":["Acta Derm Venerol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2340\/00015555-3268","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T13:32:43Z","timestamp":1563370363000},"page":"0","update-policy":"http:\/\/dx.doi.org\/10.2340\/adv_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thalidomide in Severe Hidradenitis Suppurativa: A Therapeutic Option"],"prefix":"10.2340","author":[{"given":"C","family":"Hotz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Sbidian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","container-title":["Acta Dermato Venereologica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T09:15:40Z","timestamp":1675761340000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/3381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2340\/00015555-3268","relation":{},"ISSN":["0001-5555"],"issn-type":[{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}